You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

early breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Young Patients With Early Breast Cancer

Not yet recruiting
  • Breast Cancer Female
  • operation
  • (no location specified)
Sep 6, 2023

Early Breast Cancer Trial (Ribociclib, Letrozole, Ansastrozole)

Not yet recruiting
  • Early Breast Cancer
  • (no location specified)
Apr 12, 2023

HR+/HER2-breast Cancer Trial (Standard endocrine therapy plus Apatinib)

Not yet recruiting
  • HR+/HER2-breast Cancer
  • Standard endocrine therapy plus Apatinib
  • (no location specified)
Jun 2, 2023

Breast Cancer Invasive, Hormone-receptor-positive Breast Cancer, HER2 Low Breast Carcinoma Trial in Guangzhou (Pyrotinib,

Not yet recruiting
  • Breast Cancer Invasive
  • +3 more
  • Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Nov 17, 2023

Breast Cancer Trial in Nanjing (Disitamb Vedotin ,pyrotinib)

Not yet recruiting
  • Breast Cancer
  • Disitamb Vedotin ,pyrotinib
  • Nanjing, Jiangsu, China
    Jiangsu Provincial People's Hospital
Aug 18, 2023

Breast Cancer, Clinically Assessed Negative Axillary Lymph Nodes, Sentinel Lymph Node Trial in Nanjing (Omit SLNB)

Recruiting
  • Breast Cancer
  • +2 more
  • Omit SLNB
  • Nanjing, Jiangsu, China
    the First Affiliated Hospital of Nanjing Medical University
Jul 4, 2023

Breast Cancer Trial in Angers, Saint-Herblain (Biopsy, Blood samples, Questionnaires)

Not yet recruiting
  • Breast Cancer
  • Biopsy
  • +2 more
  • Angers, France
  • +1 more
Jul 31, 2023

Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

Not yet recruiting
  • Breast Cancer, Early Breast Cancer
  • (no location specified)
Mar 7, 2023

HER2 Positive Early Breast Cancer Trial in Shanghai (Docetaxel, carboplatin, Trastuzumab)

Recruiting
  • HER2 Positive Early Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Jun 6, 2023

Breast Cancer, HER2-positive Breast Cancer Trial in São Paulo (PHESGO)

Not yet recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • São Paulo, Brazil
    Centro Paulista de Oncologia (Oncoclínicas)
Oct 3, 2023

Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

Not yet recruiting
  • Breast Cancer, Early Breast Cancer
  • (no location specified)
Jul 11, 2023

Prospective Research for Elderly Early Breast Cancer Patients

Recruiting
  • Breast Cancer Female
  • Beijing, China
    Peking Union Medical College Hospital
Dec 26, 2022

Breast Cancer Trial (Fluzoparib, Anastrozole, Letrozole)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jun 5, 2023

Cancer, Treatment-Related, Tumor of Breast, Systemic Inflammatory Response Trial in Roma (cryoablation)

Completed
  • Cancer, Treatment-Related
  • +3 more
  • cryoablation
  • Roma, Italy
    Sapienza University of Rome
Feb 13, 2023

Breast Cancer Trial (Giredestrant, Giredestrant plus triptorelin, Anastrozole plus triptorelin)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jun 13, 2023

Breast Cancer Trial in Guangzhou (Chidamide Plus Toripalimab Plus Paclitaxel)

Recruiting
  • Breast Cancer
  • Chidamide Plus Toripalimab Plus Paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 19, 2023

Early-stage Breast Cancer, Diarrhea, Adverse Drug Event Trial in Sweden (SPC-flakes, Salovum, Placebo)

Recruiting
  • Early-stage Breast Cancer
  • +2 more
  • Eskilstuna, Sweden
  • +6 more
Nov 28, 2023

Breast Cancer Trial in Milwaukee (Intermittent Fasting)

Not yet recruiting
  • Breast Cancer
  • Intermittent Fasting
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Oct 24, 2023

Older Women With ER Positive, HER2 Negative Early Breast Cancer

Enrolling by invitation
  • Breast Cancer Female
  • Translational study
  • Sutton, United Kingdom
    The Royal Marsden NHS Foundation Trust
Feb 8, 2023

Breast Cancer Trial in Ulm (Determination of tumormarkers (CA27.29, CEA, CA125), Determination of CTC levels, Determination of

Recruiting
  • Breast Cancer
  • Determination of tumormarkers (CA27.29, CEA, CA125)
  • +3 more
  • Ulm, Germany
    University Hospital Ulm Gynecology/Obstetrics
Jan 12, 2023

Breast Cancer Trial in Shanghai (The RJBC-APP, Routine post-surgical follow-up)

Not yet recruiting
  • Breast Cancer
  • The RJBC-APP
  • Routine post-surgical follow-up
  • Shanghai, Please Select, China
    Xiaosong Chen
Jun 26, 2023

Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

Not yet recruiting
  • Hormone-receptor-positive Breast Cancer
  • +3 more
  • Aromatase inhibitor
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023

Metastatic Breast Cancer, Tumor, Muscle Tumors Trial in Colorado Springs (Method(s)1 Attribution, Method(s)2 Attribution,)

Not yet recruiting
  • Metastatic Breast Cancer
  • +3 more
  • Method(s)1 Attribution
  • Method(s)2 Attribution,
  • Colorado Springs, Colorado
    PNAF Medical
Nov 23, 2023

Breast Cancer, Sentinel Lymph Node, Early-stage Breast Cancer Trial in Milano (PET/MRI)

Recruiting
  • Breast Cancer
  • +2 more
  • PET/MRI
  • Milano, MI, Italy
    Oreste Davide Gentilini
Aug 3, 2022

Three Radiation Techniques for Hypofractionated Whole Breast

Not yet recruiting
  • Breast Cancer
    • (no location specified)
    May 24, 2022